|
1 |
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland
Enthalten in BMC infectious diseases Bd. 25, 7.4.2025, Nr. 1, date:12.2025: 1-15
|
|
|
|
2 |
Assessment of eight HPV vaccination programs implemented in lowest income countries
Enthalten in BMC public health Bd. 12, 23.5.2012, Nr. 1, date:12.2012: 1-8
|
|
|
|
3 |
Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014
Enthalten in BMC health services research Bd. 16, 13.10.2016, Nr. 1, date:12.2016: 1-10
|
|
|
|
4 |
Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
Enthalten in BMC public health Bd. 14, 30.6.2014, Nr. 1, date:12.2014: 1-11
|
|
|
|
5 |
Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000–2011
Enthalten in BMC public health Bd. 13, 14.5.2013, Nr. 1, date:12.2013: 1-8
|
|
|
|
6 |
Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance
Enthalten in BMC public health Bd. 13, 1.4.2013, Nr. 1, date:12.2013: 1-10
|
|
Administration
